← Evidence map

ArticleReports (MDPI)2026

Germline BRCA2 Pathogenic Variant in Metaplastic Breast Carcinoma with Heterologous Mesenchymal Differentiation: A Case Report and Literature Review.

Alice Arduini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Germline BRCA2 Pathogenic Variant in Metaplastic Breast Carcinoma with Heterologous Mesenchymal Differentiation: A Case Report and Literature Review. | OpenQuestion